Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells

Qi Qi(Bengbu Medical College), Qinglong Guo(China Pharmaceutical University), Hong-Yan Gu(China Pharmaceutical University), Wei Liu(Beijing Institute of Fashion Technology), Yong Yang(Shandong University of Traditional Chinese Medicine), Chenglin Li(Zhejiang Normal University), Qidong You(China Pharmaceutical University), Xiaotang Wang(Shanxi Medical University), Na Lu(Shandong Maternal and Child Health Hospital)
Biochemistry and Cell Biology
October 1, 2008
10.1139/o08-104
Cited by 53

Related Papers

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Correction: Corrigendum: The OncoPPi network of cancer-focused protein–protein interactions to inform biological insights and therapeutic strategies
|Nature Communications|2017|645
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Quercetin alleviates acute kidney injury by inhibiting ferroptosis
|Journal of Advanced Research|2020|601
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587